Global Biothrax (Anthrax Vaccine) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
The Biothrax (Anthrax Vaccine) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biothrax (Anthrax Vaccine) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Biothrax (Anthrax Vaccine) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biothrax (Anthrax Vaccine) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Cell Free PA Vaccines
Market segment by Application can be divided into
Human Use
Animal Use
The key market players for global Biothrax (Anthrax Vaccine) market are listed below:
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Biothrax (Anthrax Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biothrax (Anthrax Vaccine), with price, sales, revenue and global market share of Biothrax (Anthrax Vaccine) in 2018 and 2019.
Chapter 3, the Biothrax (Anthrax Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biothrax (Anthrax Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Biothrax (Anthrax Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Biothrax (Anthrax Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biothrax (Anthrax Vaccine) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biothrax (Anthrax Vaccine) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Biothrax (Anthrax Vaccine) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Biothrax (Anthrax Vaccine) Market Size & Forecast
1.4.1 Global Biothrax (Anthrax Vaccine) Sales in Value (2016-2026))
1.4.2 Global Biothrax (Anthrax Vaccine) Sales in Volume (2016-2026)
1.4.3 Global Biothrax (Anthrax Vaccine) Price by Type (2016-2026) & (US$/Unit)
1.5 Global Biothrax (Anthrax Vaccine) Production Capacity Analysis
1.5.1 Global Biothrax (Anthrax Vaccine) Total Production Capacity (2016-2026)
1.5.2 Global Biothrax (Anthrax Vaccine) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biothrax (Anthrax Vaccine) Market Drivers
1.6.2 Biothrax (Anthrax Vaccine) Market Restraints
1.6.3 Biothrax (Anthrax Vaccine) Trends Analysis
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business
2.1.3 Merial Biothrax (Anthrax Vaccine) Product and Services
2.1.4 Merial Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Biothrax (Anthrax Vaccine) Product and Services
2.2.4 Merck Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Biothrax (Anthrax Vaccine) Product and Services
2.3.4 Zoetis Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer Sanidad Animal
2.4.1 Bayer Sanidad Animal Details
2.4.2 Bayer Sanidad Animal Major Business
2.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product and Services
2.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Colorado Serum
2.5.1 Colorado Serum Details
2.5.2 Colorado Serum Major Business
2.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Product and Services
2.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 PharmAthene
2.6.1 PharmAthene Details
2.6.2 PharmAthene Major Business
2.6.3 PharmAthene Biothrax (Anthrax Vaccine) Product and Services
2.6.4 PharmAthene Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Tiankang
2.7.1 Tiankang Details
2.7.2 Tiankang Major Business
2.7.3 Tiankang Biothrax (Anthrax Vaccine) Product and Services
2.7.4 Tiankang Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Biogénesis-Bago
2.8.1 Biogénesis-Bago Details
2.8.2 Biogénesis-Bago Major Business
2.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product and Services
2.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 CAVAC
2.9.1 CAVAC Details
2.9.2 CAVAC Major Business
2.9.3 CAVAC Biothrax (Anthrax Vaccine) Product and Services
2.9.4 CAVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Rosenbusch
2.10.1 Rosenbusch Details
2.10.2 Rosenbusch Major Business
2.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Product and Services
2.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Agrovet
2.11.1 Agrovet Details
2.11.2 Agrovet Major Business
2.11.3 Agrovet Biothrax (Anthrax Vaccine) Product and Services
2.11.4 Agrovet Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Vecol
2.12.1 Vecol Details
2.12.2 Vecol Major Business
2.12.3 Vecol Biothrax (Anthrax Vaccine) Product and Services
2.12.4 Vecol Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 CVCRI
2.13.1 CVCRI Details
2.13.2 CVCRI Major Business
2.13.3 CVCRI Biothrax (Anthrax Vaccine) Product and Services
2.13.4 CVCRI Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 IVPM
2.14.1 IVPM Details
2.14.2 IVPM Major Business
2.14.3 IVPM Biothrax (Anthrax Vaccine) Product and Services
2.14.4 IVPM Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Prondil
2.15.1 Prondil Details
2.15.2 Prondil Major Business
2.15.3 Prondil Biothrax (Anthrax Vaccine) Product and Services
2.15.4 Prondil Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 CDV
2.16.1 CDV Details
2.16.2 CDV Major Business
2.16.3 CDV Biothrax (Anthrax Vaccine) Product and Services
2.16.4 CDV Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Indian Immunologicals
2.17.1 Indian Immunologicals Details
2.17.2 Indian Immunologicals Major Business
2.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Product and Services
2.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Botswana Vaccine Institute
2.18.1 Botswana Vaccine Institute Details
2.18.2 Botswana Vaccine Institute Major Business
2.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product and Services
2.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Ceva Santé Animale
2.19.1 Ceva Santé Animale Details
2.19.2 Ceva Santé Animale Major Business
2.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product and Services
2.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Intervac
2.20.1 Intervac Details
2.20.2 Intervac Major Business
2.20.3 Intervac Biothrax (Anthrax Vaccine) Product and Services
2.20.4 Intervac Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 JOVAC
2.21.1 JOVAC Details
2.21.2 JOVAC Major Business
2.21.3 JOVAC Biothrax (Anthrax Vaccine) Product and Services
2.21.4 JOVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Biothrax (Anthrax Vaccine) Sales by Manufacturer
3.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Biothrax (Anthrax Vaccine) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Biothrax (Anthrax Vaccine)
3.4 Market Concentration Rate
3.4.1 Top 3 Biothrax (Anthrax Vaccine) Manufacturer Market Share
3.4.2 Top 6 Biothrax (Anthrax Vaccine) Manufacturer Market Share
3.5 Global Biothrax (Anthrax Vaccine) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Biothrax (Anthrax Vaccine) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biothrax (Anthrax Vaccine) Market Size by Region
4.1.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Region (2016-2026)
4.1.2 Global Biothrax (Anthrax Vaccine) Revenue by Region (2016-2026)
4.2 North America Biothrax (Anthrax Vaccine) Revenue (2016-2026)
4.3 Europe Biothrax (Anthrax Vaccine) Revenue (2016-2026)
4.4 Asia-Pacific Biothrax (Anthrax Vaccine) Revenue (2016-2026)
4.5 South America Biothrax (Anthrax Vaccine) Revenue (2016-2026)
4.6 Middle East and Africa Biothrax (Anthrax Vaccine) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Type (2016-2026)
5.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2016-2026)
5.3 Global Biothrax (Anthrax Vaccine) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Application (2016-2026)
6.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2016-2026)
6.3 Global Biothrax (Anthrax Vaccine) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Biothrax (Anthrax Vaccine) Sales by Type (2016-2026)
7.2 North America Biothrax (Anthrax Vaccine) Sales by Application (2016-2026)
7.3 North America Biothrax (Anthrax Vaccine) Market Size by Country
7.3.1 North America Biothrax (Anthrax Vaccine) Sales in Volume by Country (2016-2026)
7.3.2 North America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Biothrax (Anthrax Vaccine) Sales by Type (2016-2026)
8.2 Europe Biothrax (Anthrax Vaccine) Sales by Application (2016-2026)
8.3 Europe Biothrax (Anthrax Vaccine) Market Size by Country
8.3.1 Europe Biothrax (Anthrax Vaccine) Sales in Volume by Country (2016-2026)
8.3.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Type (2016-2026)
9.2 Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Application (2016-2026)
9.3 Asia-Pacific Biothrax (Anthrax Vaccine) Market Size by Region
9.3.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Biothrax (Anthrax Vaccine) Sales by Type (2016-2026)
10.2 South America Biothrax (Anthrax Vaccine) Sales by Application (2016-2026)
10.3 South America Biothrax (Anthrax Vaccine) Market Size by Country
10.3.1 South America Biothrax (Anthrax Vaccine) Sales in Volume by Country (2016-2026)
10.3.2 South America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2016-2026)
11.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2016-2026)
11.3 Middle East & Africa Biothrax (Anthrax Vaccine) Market Size by Country
11.3.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Biothrax (Anthrax Vaccine) Typical Distributors
12.3 Biothrax (Anthrax Vaccine) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Biothrax (Anthrax Vaccine) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Biothrax (Anthrax Vaccine) Revenue by Application, (USD Million), 2021-2026
Table 3. Merial Basic Information, Manufacturing Base and Competitors
Table 4. Merial Major Business
Table 5. Merial Biothrax (Anthrax Vaccine) Product and Services
Table 6. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Biothrax (Anthrax Vaccine) Product and Services
Table 10. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zoetis Basic Information, Manufacturing Base and Competitors
Table 12. Zoetis Major Business
Table 13. Zoetis Biothrax (Anthrax Vaccine) Product and Services
Table 14. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Sanidad Animal Major Business
Table 17. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product and Services
Table 18. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 20. Colorado Serum Major Business
Table 21. Colorado Serum Biothrax (Anthrax Vaccine) Product and Services
Table 22. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. PharmAthene Basic Information, Manufacturing Base and Competitors
Table 24. PharmAthene Major Business
Table 25. PharmAthene Biothrax (Anthrax Vaccine) Product and Services
Table 26. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Tiankang Basic Information, Manufacturing Base and Competitors
Table 28. Tiankang Major Business
Table 29. Tiankang Biothrax (Anthrax Vaccine) Product and Services
Table 30. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biogénesis-Bago Basic Information, Manufacturing Base and Competitors
Table 32. Biogénesis-Bago Major Business
Table 33. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product and Services
Table 34. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. CAVAC Basic Information, Manufacturing Base and Competitors
Table 36. CAVAC Major Business
Table 37. CAVAC Biothrax (Anthrax Vaccine) Product and Services
Table 38. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 40. Rosenbusch Major Business
Table 41. Rosenbusch Biothrax (Anthrax Vaccine) Product and Services
Table 42. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Agrovet Basic Information, Manufacturing Base and Competitors
Table 44. Agrovet Major Business
Table 45. Agrovet Biothrax (Anthrax Vaccine) Product and Services
Table 46. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Vecol Basic Information, Manufacturing Base and Competitors
Table 48. Vecol Major Business
Table 49. Vecol Biothrax (Anthrax Vaccine) Product and Services
Table 50. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. CVCRI Basic Information, Manufacturing Base and Competitors
Table 52. CVCRI Major Business
Table 53. CVCRI Biothrax (Anthrax Vaccine) Product and Services
Table 54. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. IVPM Basic Information, Manufacturing Base and Competitors
Table 56. IVPM Major Business
Table 57. IVPM Biothrax (Anthrax Vaccine) Product and Services
Table 58. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Prondil Basic Information, Manufacturing Base and Competitors
Table 60. Prondil Major Business
Table 61. Prondil Biothrax (Anthrax Vaccine) Product and Services
Table 62. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. CDV Basic Information, Manufacturing Base and Competitors
Table 64. CDV Major Business
Table 65. CDV Biothrax (Anthrax Vaccine) Product and Services
Table 66. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 68. Indian Immunologicals Major Business
Table 69. Indian Immunologicals Biothrax (Anthrax Vaccine) Product and Services
Table 70. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Botswana Vaccine Institute Basic Information, Manufacturing Base and Competitors
Table 72. Botswana Vaccine Institute Major Business
Table 73. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product and Services
Table 74. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 76. Ceva Santé Animale Major Business
Table 77. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product and Services
Table 78. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Intervac Basic Information, Manufacturing Base and Competitors
Table 80. Intervac Major Business
Table 81. Intervac Biothrax (Anthrax Vaccine) Product and Services
Table 82. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. JOVAC Basic Information, Manufacturing Base and Competitors
Table 84. JOVAC Major Business
Table 85. JOVAC Biothrax (Anthrax Vaccine) Product and Services
Table 86. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Biothrax (Anthrax Vaccine) Sales by Manufacturer (2019-2021e) & (K Units)
Table 88. Global Biothrax (Anthrax Vaccine) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Biothrax (Anthrax Vaccine), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Biothrax (Anthrax Vaccine) Production Capacity by Company, (K Units): 2020 VS 2021
Table 91. Head Office and Biothrax (Anthrax Vaccine) Production Site of Key Manufacturer
Table 92. Biothrax (Anthrax Vaccine) New Entrant and Capacity Expansion Plans
Table 93. Biothrax (Anthrax Vaccine) Mergers & Acquisitions in the Past Five Years
Table 94. Global Biothrax (Anthrax Vaccine) Sales by Region (2016-2021e) & (K Units)
Table 95. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units)
Table 96. Global Biothrax (Anthrax Vaccine) Revenue by Region (2016-2021e) & (USD Million)
Table 97. Global Biothrax (Anthrax Vaccine) Revenue by Region (2021-2026) & (USD Million)
Table 98. Global Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 99. Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 100. Global Biothrax (Anthrax Vaccine) Revenue by Type (2016-2021e) & (USD Million)
Table 101. Global Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (USD Million)
Table 102. Global Biothrax (Anthrax Vaccine) Price by Type (2016-2021e) & (US$/Unit)
Table 103. Global Biothrax (Anthrax Vaccine) Price by Type (2021-2026) & (US$/Unit)
Table 104. Global Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 105. Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 106. Global Biothrax (Anthrax Vaccine) Revenue by Application (2016-2021e) & (USD Million)
Table 107. Global Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (USD Million)
Table 108. Global Biothrax (Anthrax Vaccine) Price by Application (2016-2021e) & (US$/Unit)
Table 109. Global Biothrax (Anthrax Vaccine) Price by Application (2021-2026) & (US$/Unit)
Table 110. North America Biothrax (Anthrax Vaccine) Sales by Country (2016-2021e) & (K Units)
Table 111. North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units)
Table 112. North America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021e) & (USD Million)
Table 113. North America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (USD Million)
Table 114. North America Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 115. North America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 116. North America Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 117. North America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 118. Europe Biothrax (Anthrax Vaccine) Sales by Country (2016-2021e) & (K Units)
Table 119. Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units)
Table 120. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021e) & (USD Million)
Table 121. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (USD Million)
Table 122. Europe Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 123. Europe Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 124. Europe Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 125. Europe Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 126. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Region (2016-2021e) & (K Units)
Table 127. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units)
Table 128. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2016-2021e) & (USD Million)
Table 129. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2021-2026) & (USD Million)
Table 130. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 131. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 132. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 133. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 134. South America Biothrax (Anthrax Vaccine) Sales by Country (2016-2021e) & (K Units)
Table 135. South America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units)
Table 136. South America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021e) & (USD Million)
Table 137. South America Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (USD Million)
Table 138. South America Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 139. South America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 140. South America Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 141. South America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 142. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2016-2021e) & (K Units)
Table 143. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units)
Table 144. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021e) & (USD Million)
Table 145. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2021-2026) & (USD Million)
Table 146. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2016-2021e) & (K Units)
Table 147. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units)
Table 148. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2016-2021e) & (K Units)
Table 149. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Biothrax (Anthrax Vaccine) Typical Distributors
Table 153. Biothrax (Anthrax Vaccine) Typical Customers
List of Figures
Figure 1. Biothrax (Anthrax Vaccine) Picture
Figure 2. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type in 2020
Figure 3. Live Vaccines
Figure 4. Cell Free PA Vaccines
Figure 5. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2020
Figure 6. Human Use
Figure 7. Animal Use
Figure 8. Global Biothrax (Anthrax Vaccine) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Biothrax (Anthrax Vaccine) Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Biothrax (Anthrax Vaccine) Sales (2016-2026) & (K Units)
Figure 11. Global Biothrax (Anthrax Vaccine) Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Biothrax (Anthrax Vaccine) Production Capacity (2016-2026) & (K Units)
Figure 13. Global Biothrax (Anthrax Vaccine) Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Biothrax (Anthrax Vaccine) Market Drivers
Figure 15. Biothrax (Anthrax Vaccine) Market Restraints
Figure 16. Biothrax (Anthrax Vaccine) Market Trends
Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturer in 2020
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturer in 2020
Figure 19. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Biothrax (Anthrax Vaccine) Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Biothrax (Anthrax Vaccine) Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2026)
Figure 23. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2016-2026)
Figure 24. North America Biothrax (Anthrax Vaccine) Revenue (2016-2026) & (USD Million)
Figure 25. Europe Biothrax (Anthrax Vaccine) Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue (2016-2026) & (USD Million)
Figure 27. South America Biothrax (Anthrax Vaccine) Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue (2016-2026) & (USD Million)
Figure 29. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2026)
Figure 30. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2016-2026)
Figure 31. Global Biothrax (Anthrax Vaccine) Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 33. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2016-2026)
Figure 34. Global Biothrax (Anthrax Vaccine) Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2026)
Figure 36. North America Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 37. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2026)
Figure 38. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2026)
Figure 39. United States Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2026)
Figure 43. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 44. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2026)
Figure 45. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2026)
Figure 46. Germany Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2016-2026)
Figure 55. China Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2026)
Figure 62. South America Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 63. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2026)
Figure 64. South America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
